Teva Gets Tentative OK to Sell Copies of Zocor
- Share via
Israel-based Teva Pharmaceutical Industries Ltd. won tentative U.S. regulatory approval to sell copies of Merck & Co.’s Zocor cholesterol drug, and said sales might start in June.
Still at issue is the ability of Teva, the world’s biggest generic drug maker, to sell the pills exclusively for six months under a U.S. rule designed to promote cheaper generics.
Teva said the Food and Drug Administration had appealed a May 1 court ruling favoring exclusivity, which an analyst said could add $350 million to the company’s 2006 sales.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
